DE69922916D1 - Polypropylenbasierte behälter für prostaglandin-enthaltende produkte - Google Patents

Polypropylenbasierte behälter für prostaglandin-enthaltende produkte

Info

Publication number
DE69922916D1
DE69922916D1 DE69922916T DE69922916T DE69922916D1 DE 69922916 D1 DE69922916 D1 DE 69922916D1 DE 69922916 T DE69922916 T DE 69922916T DE 69922916 T DE69922916 T DE 69922916T DE 69922916 D1 DE69922916 D1 DE 69922916D1
Authority
DE
Germany
Prior art keywords
containing products
polypropylene based
based containers
prostaglandin containing
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69922916T
Other languages
English (en)
Other versions
DE69922916T2 (de
Inventor
L Weiner
C Airy
Cody Yarborough
A Clifford
E Mccune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Research LLC
Original Assignee
Alcon Manufacturing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22235155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69922916(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Manufacturing Ltd filed Critical Alcon Manufacturing Ltd
Publication of DE69922916D1 publication Critical patent/DE69922916D1/de
Application granted granted Critical
Publication of DE69922916T2 publication Critical patent/DE69922916T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DE69922916T 1998-07-14 1999-06-15 Polypropylenbasierte behälter für prostaglandin-enthaltende produkte Expired - Lifetime DE69922916T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9278698P 1998-07-14 1998-07-14
US92786P 1998-07-14
PCT/US1999/013276 WO2000003736A1 (en) 1998-07-14 1999-06-15 Prostaglandin product

Publications (2)

Publication Number Publication Date
DE69922916D1 true DE69922916D1 (de) 2005-02-03
DE69922916T2 DE69922916T2 (de) 2005-06-09

Family

ID=22235155

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69922916T Expired - Lifetime DE69922916T2 (de) 1998-07-14 1999-06-15 Polypropylenbasierte behälter für prostaglandin-enthaltende produkte

Country Status (16)

Country Link
EP (1) EP1011728B1 (de)
JP (2) JP2002520368A (de)
KR (1) KR20010021835A (de)
CN (1) CN1146423C (de)
AR (1) AR019773A1 (de)
AT (1) ATE285795T1 (de)
AU (1) AU743607B2 (de)
BR (1) BR9906597A (de)
CA (1) CA2295512C (de)
DE (1) DE69922916T2 (de)
ES (1) ES2234270T3 (de)
HK (1) HK1028563A1 (de)
PT (1) PT1011728E (de)
TW (1) TW585769B (de)
WO (1) WO2000003736A1 (de)
ZA (1) ZA997794B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina
EP1159266B1 (de) 1999-03-05 2004-11-03 Duke University C-16 ungesätigte fp-selektive prostaglandin analoge
WO2001019790A1 (fr) * 1999-09-10 2001-03-22 Taisho Pharmaceutical Co., Ltd. Derives de prostaglandine
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
AU2002212234A1 (en) * 2000-09-14 2002-03-26 Novartis Ag Stable ophthalmic preparation
CA2477418A1 (en) 2002-03-18 2003-09-25 Santen Pharmaceutical Co., Ltd. High-temperature-sterilizable instillator
AU2003262268A1 (en) * 2002-08-23 2004-04-30 Santen Pharmaceutical Co., Ltd. Stable eye drops containing latanoprost as the active ingredient
DE602004024427D1 (de) * 2003-07-31 2010-01-14 Santen Pharmaceutical Co Ltd Prostaglandin enthaltendes produkt
US20080139648A1 (en) * 2004-12-09 2008-06-12 Santen Pharmaceutical Co., Ltd. Product Containing Prostaglandin Having Fluorine Atom In Its Molecule
JP4753178B2 (ja) * 2004-12-24 2011-08-24 参天製薬株式会社 プロスタグランジンＦ２α誘導体含有製品
CN101175496A (zh) * 2004-12-24 2008-05-07 参天制药株式会社 含有前列腺素F2α衍生物的制品
ES2460967T3 (es) * 2005-08-02 2014-05-16 Santen Pharmaceutical Co., Ltd. Método para la prevención de la degradación de una sustancia térmicamente inestable
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
KR101382922B1 (ko) * 2006-03-13 2014-04-08 가부시키가이샤 아루떼꾸 우에노 수성 조성물
CN105566192B (zh) * 2006-10-02 2019-01-22 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
WO2008096804A1 (ja) 2007-02-07 2008-08-14 Teika Pharmaceutical Co., Ltd. ラタノプロスト含有点眼剤
EP2193795B1 (de) 2007-08-29 2014-10-01 Wakamoto Pharmaceutical Co., Ltd. Latanoprosthaltige wässrige pharmazeutische zusammensetzung
MX2010004211A (es) * 2007-10-16 2010-06-30 Sun Pharma Advanced Res Co Ltd Composicion oftalmica que comprende una prostaglandina.
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
JP2009256281A (ja) * 2008-04-21 2009-11-05 Teika Seiyaku Kk イソプロピルウノプロストン含有点眼剤組成物
EP2127638A1 (de) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
MX2011008647A (es) * 2009-02-20 2011-10-28 Micro Labs Ltd Producto de prostaglandina de almacenamiento estable.
JP2012525386A (ja) 2009-05-01 2012-10-22 アエリエ・ファーマシューティカルズ・インコーポレーテッド 疾患の治療のための二重機構阻害剤
DE102009021372A1 (de) * 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
TW201113022A (en) * 2009-09-01 2011-04-16 R Tech Ueno Ltd Composition for ocular local-administration for treating ocular hypertension and glaucoma
US20120184552A1 (en) 2009-09-17 2012-07-19 Senju Pharmaceutical Co., Ltd. Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
EP2627173B2 (de) * 2010-10-12 2018-07-04 Chiesi Farmaceutici S.p.A. Clevidipin-emulsionsformulierungen mit antimikrobiellen mitteln
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2452669A1 (de) 2010-10-29 2012-05-16 Omnivision GmbH Ophthalmische Zusammensetzung
EP2567689A1 (de) 2011-09-12 2013-03-13 Visiotact Pharma Ophthalmische Zusammensetzungen enhaltend Prostaglandin-F2-alpha-Derivate und Hyaluronsäure
PT3811943T (pt) 2013-03-15 2023-03-15 Aerie Pharmaceuticals Inc Composto para uso no tratamento de distúrbios oculares
WO2015105134A1 (ja) * 2014-01-10 2015-07-16 参天製薬株式会社 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
EP3093019B1 (de) 2014-01-10 2021-05-26 Santen Pharmaceutical Co., Ltd Pharmazeutische zusammensetzung mit pyridylaminoessigsäureverbindung
SG11201704735WA (en) * 2014-12-12 2017-07-28 Kowa Co Composition
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
KR102568079B1 (ko) * 2016-08-31 2023-08-17 에어리 파마슈티컬즈, 인코포레이티드 안과용 조성물
MX2019011784A (es) 2017-03-31 2019-11-18 Aerie Pharmaceuticals Inc Compuestos de aril ciclopropil-amino-isoquinolinil amida.
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5425480A (en) * 1992-12-17 1995-06-20 Ryder International Corporation Dose dispenser having a molded plastic housing with a cavity and a metallic foil wall covering the cavity
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
JPH09124484A (ja) 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina

Also Published As

Publication number Publication date
KR20010021835A (ko) 2001-03-15
CA2295512A1 (en) 2000-01-14
AU743607B2 (en) 2002-01-31
HK1028563A1 (en) 2001-02-23
AU4822099A (en) 2000-02-07
JP2010100652A (ja) 2010-05-06
DE69922916T2 (de) 2005-06-09
ES2234270T3 (es) 2005-06-16
CA2295512C (en) 2009-05-26
JP2002520368A (ja) 2002-07-09
TW585769B (en) 2004-05-01
WO2000003736A1 (en) 2000-01-27
EP1011728B1 (de) 2004-12-29
ZA997794B (en) 2001-01-02
PT1011728E (pt) 2005-03-31
AR019773A1 (es) 2002-03-13
EP1011728A1 (de) 2000-06-28
ATE285795T1 (de) 2005-01-15
CN1272063A (zh) 2000-11-01
BR9906597A (pt) 2000-07-18
CN1146423C (zh) 2004-04-21

Similar Documents

Publication Publication Date Title
DE69922916D1 (de) Polypropylenbasierte behälter für prostaglandin-enthaltende produkte
ATE260593T1 (de) Belüfteter behälter für produkte
DE69811232T2 (de) Behälter für anaerobe produkte
DE69935730D1 (de) Indikator für aerosolcontainer
ATE303953T1 (de) Stapelbare kästen für flaschen niedriger tiefe
DE60036630D1 (de) Behälter für kosmetische produkte
DE69926732T2 (de) Abnehmbarer verschluss für kunststoffbehälter
DE69915291D1 (de) Abgabevorrichtung für fliessfähige Produkte
DE69505454T2 (de) Verpackung für Behälter
DE69911696D1 (de) Behälter für Kosmetische Produkte
DE69505453D1 (de) Verpackung für Behälter
DE69809441D1 (de) Verpackungsschachtel für nahrungsmitteln
NO20004543D0 (no) Beholder for jordbruksprodukter
DE69700073T2 (de) Ausgabebehälter für fliessfähige Produkte
DE29810863U1 (de) Hülle für Getränkeverpackungen
DE29716230U1 (de) Verpackung für fließfähige Medien
SE9402115D0 (sv) Verpackung für bogenförmige produkte
DE29718278U1 (de) Verpackung für hygroskopische Produkte
DK1011728T3 (da) Polypropylenbeholdere til prostaglandinprodukter
DE29812678U1 (de) Rücknahmestation für Mehrwegbehälter
DE9417949U1 (de) Stülpdeckel für Behältnisse
DE29718826U1 (de) Isolierbehälter für Konditorwaren
DE29617814U1 (de) Versandverpackung für flache Produkte
DE29809350U1 (de) Behälter für längliche Gegenstände
DE59802868D1 (de) Transportgebinde für flüssigkeiten

Legal Events

Date Code Title Description
8363 Opposition against the patent